Table 3.
Ingenuity canonical pathways | –log (p-value) | Ratio | z-score |
---|---|---|---|
Epithelial adherens junction signaling | 6.62E00 | 2.23E-01 | NaN |
ILK signaling | 6.13E00 | 1.96E-01 | −3.33 |
Axonal guidance signaling | 5.87E00 | 1.53E-01 | NaN |
Germ cell-sertoli cell junction signaling | 5.73E00 | 1.99E-01 | NaN |
Integrin signaling | 5.42E00 | 1.82E-01 | −4.23 |
Acute myeloid leukemia signaling | 4.83E00 | 2.29E-01 | −2.98 |
Sertoli cell-sertoli cell junction signaling | 4.76E00 | 1.83E-01 | NaN |
RhoGDI signaling | 4.51E00 | 1.8E-01 | 3.02 |
Hepatic fibrosis/hepatic stellate cell activation | 4.51E00 | 1.78E-01 | NaN |
IL-8 signaling | 4.41E00 | 1.74E-01 | −4.70 |
Breast cancer regulation by Stathmin1 | 4.33E00 | 1.71E-01 | NaN |
ERK/MAPK signaling | 4.28E00 | 1.72E-01 | −1.71 |
Actin cytoskeleton signaling | 4.18E00 | 1.65E-01 | −4.56 |
PTEN signaling | 4.11E00 | 1.98E-01 | 3.27 |
Fcγ receptor-mediated phagocytosis in macrophages and monocytes | 4.11E00 | 2.12E-01 | −4.15 |
Signaling by Rho family GTPases | 3.93E00 | 1.57E-01 | −4.80 |
Remodeling of epithelial adherens junctions | 3.74E00 | 2.32E-01 | NaN |
Chronic myeloid leukemia signaling | 3.67E00 | 1.98E-01 | NaN |
Reelin signaling in neurons | 3.62E00 | 2.07E-01 | NaN |
Ephrin receptor signaling | 3.62E00 | 1.69E-01 | −3.92 |
VEGF signaling | 3.49E00 | 1.93E-01 | −2.98 |
FAK signaling | 3.46E00 | 1.96E-01 | NaN |
CDK5 signaling | 3.40E00 | 1.94E-01 | −0.45 |
Tight junction signaling | 3.38E00 | 1.68E-01 | NaN |
Adipogenesis pathway | 3.36E00 | 1.78E-01 | NaN |